“A Quick Guide to Clinical Trials” Book Review
A brief review of “A Quick Guide to Clinical Trials,” edited by Dr. Madhu Davies and Dr. Faiz Kermain.
May 14, 2008-“A Quick Guide to Clinical Trials,” edited by Dr. Madhu Davies and Dr. Faiz Kermain, and offered by BioPlan Associates, truly lives up to its title. While it could serve as a textbook for a primer class on the clinical trials industry, the quick read would be suitable for anyone wishing to learn more about clinical trials-including people outside or inside the industry. If you are in data management, for example, and want to learn more about ethics in clinical research-or vise versa-this would be a useful resource. The book consists of 14 chapters dedicated to a different segment of the clinical trials process, each written by an industry expert. The information is up-to-date and offers personal, yet professional, insights into the current issues applicable to that segment.
For more information or to purchase, contact: www.bioplanassociates.com/quickGuides.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
